Ancora Advisors LLC Takes Position in Amrize Ltd $AMRZ

Key Points

• Ancora Advisors acquired 283,522 Amrize shares worth approximately $15.1 million, giving it a 0.05% stake. Other institutional investors have also recently initiated or increased positions.
• Amrize shares fell 2% to $44.26, near their one-year low, after the company reported quarterly EPS of $0.88, missing the $0.92 consensus estimate. Revenue totaled $3.49 billion.
• Analysts maintain a consensus “Moderate Buy” rating with an average price target of $59.87, while insiders purchased 14,828 shares worth about $697,000 over the past three months. The company also announced a quarterly dividend of $0.11 per share.

Ancora Advisors LLC acquired a new position in Amrize Ltd (NYSE:AMRZ - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 283,522 shares of the company's stock, valued at approximately $15,112,000. Ancora Advisors LLC owned 0.05% of Amrize as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. MCF Advisors LLC purchased a new stake in Amrize during the fourth quarter valued at approximately $27,000. Basepoint Wealth LLC bought a new stake in shares of Amrize during the 4th quarter valued at $33,000. Laurel Wealth Advisors LLC purchased a new stake in shares of Amrize in the 4th quarter worth $34,000. US Bancorp DE purchased a new stake in shares of Amrize in the 3rd quarter worth $38,000. Finally, Itau Unibanco Holding S.A. raised its holdings in Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company's stock worth $41,000 after purchasing an additional 450 shares during the period.

Amrize Trading Down 2.0%

Shares of AMRZ opened at $44.26 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. Amrize Ltd has a 1 year low of $43.69 and a 1 year high of $65.94. The company has a 50 day simple moving average of $50.14 and a two-hundred day simple moving average of $54.03. The firm has a market cap of $24.48 billion, a P/E ratio of 20.40, a price-to-earnings-growth ratio of 1.00 and a beta of 0.11.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $3.49 billion during the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. On average, equities analysts expect that Amrize Ltd will post 2.74 earnings per share for the current fiscal year.

Amrize Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th will be issued a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, August 18th. Amrize's dividend payout ratio is 20.28%.

Wall Street Analysts Forecast Growth

AMRZ has been the topic of several analyst reports. Truist Financial reiterated a "hold" rating and set a $48.00 target price (down from $65.00) on shares of Amrize in a research report on Tuesday, July 7th. Vertical Research raised Amrize from a "hold" rating to a "buy" rating and set a $70.00 price objective on the stock in a research note on Friday, May 1st. Citigroup lowered their price objective on Amrize from $66.00 to $58.00 and set a "buy" rating on the stock in a research report on Tuesday, August 11th. Wells Fargo & Company cut their price objective on Amrize from $65.00 to $58.00 and set an "overweight" rating for the company in a research note on Wednesday, July 8th. Finally, Weiss Ratings raised shares of Amrize from a "sell (d+)" rating to a "hold (c)" rating in a report on Thursday, August 13th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $59.87.

Insider Buying and Selling at Amrize

In other news, CTO Roald Brouwer acquired 1,500 shares of the business's stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average price of $46.36 per share, for a total transaction of $69,540.00. Following the completion of the transaction, the chief technology officer directly owned 21,490 shares in the company, valued at approximately $996,276.40. This trade represents a 7.50% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Baris Oran bought 3,000 shares of Amrize stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the acquisition, the chief financial officer directly owned 3,000 shares of the company's stock, valued at approximately $142,140. The trade was a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have purchased 14,828 shares of company stock worth $697,479. Insiders own 0.54% of the company's stock.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.